Dr Reddys Laboratories announces launch of 2 separate products in Indian & US market
Dr Reddys Laboratories announces launch of 2 separate products in Indian & US market

Dr Reddys Laboratories announces launch of 2 separate products in Indian & US market

Rishikesh Gaikwad Article rating: 4.3

Dr Reddy’s Laboratories Ltd announced the launch of Remdesivir along with its subsidiaries on Wednesday. The product is being launched under the brand name of Redyx in India. Additionally, it also announced the launch of over-the-counter (OTC) Diclofenac Sodium Topical Gel 1 per cent, the store brand version of Voltaren® Arthritis Pain in the US market.

Vodafone Idea to launch a single brand ‘Vi
Vodafone Idea to launch a single brand ‘Vi

Vodafone Idea to launch a single brand ‘Vi

Rishikesh Gaikwad Article rating: 4.1

Vodafone Idea Limited informed on Monday that after almost two years of merging as a single entity, it will now also have a single brand name. The company has announced the new brand to be called ‘Vi’ (read as ‘we’). The company believes that this integration of two brands is the largest telecom integration in the world.

Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection
Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection

Alembic Global Holding SA receives USFDA tentative approval for Treprostinil injection

Rishikesh Gaikwad Article rating: 5.0

Alembic Pharmaceuticals Limited announced on Monday that its wholly-owned subsidiary, Alembic Global Holding SA has received tentative approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Treprostinil Injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials.

Strides Pharma receives USFDA approval for Prednisone tablets
Strides Pharma receives USFDA approval for Prednisone tablets

Strides Pharma receives USFDA approval for Prednisone tablets

Rishikesh Gaikwad Article rating: 5.0

Strides Pharma Science Limited (Strides) announced on Thursday that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited (Singapore) has received approval for Prednisone tablets USP, 1 mg from United States Food & Drug Administration (USFDA). The product is a generic version of Meticorten tablets, 1 mg of Schering Corporation.

Hexaware shines on partnering with ICT Academy for corporate initiatives
Hexaware shines on partnering with ICT Academy for corporate initiatives

Hexaware shines on partnering with ICT Academy for corporate initiatives

Rishikesh Gaikwad Article rating: 2.9

Hexaware Technologies Limited announced that it has partnered with ICT Academy, a not-for-profit organisation, to train 500 final year students from rural colleges in Tamil Nadu, Puducherry, Andhra Pradesh, Maharashtra, and Telangana, on technical and soft skills relevant for the IT Industry.

Parag Milk Foods Limited launches premium ghee brand
Parag Milk Foods Limited launches premium ghee brand

Parag Milk Foods Limited launches premium ghee brand

Rishikesh Gaikwad Article rating: 2.8

Parag Milk Foods Limited, a dairy FMCG company, launched Pride of Cows ‘single-origin ghee’ on Monday. Famous for brands like ‘Gowardhan’, ‘Go’, ‘Pride of Cows’, and ‘Avvatar’, the single-origin ghee is procured from Pride of Cows milk, the first-of-its-kind farm-to-home milk.

One year returns analysis of Nifty & Nifty companies
One year returns analysis of Nifty & Nifty companies

One year returns analysis of Nifty & Nifty companies

Rishikesh Gaikwad Article rating: 2.3

We analysed the last one year's returns of Nifty as an index and its constituents too in the last one year, starting from August 27, 2019, till August 27, 2020. Over this period, Nifty gave an absolute return of a mere 4.09 per cent. Surprisingly, there was enough disparity in Nifty constituents with regard to the returns they gave individually.

Dr Reddy's Laboratories to launch Penicillamine capsules in US market
Dr Reddy's Laboratories to launch Penicillamine capsules in US market

Dr Reddy's Laboratories to launch Penicillamine capsules in US market

Rishikesh Gaikwad Article rating: 5.0

Dr Reddy’s Laboratories Ltd announced the launch of Penicillamine capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine (Penicillamine) capsules, 250 mg, approved by United States Food & Drug Administration (USFDA) on Thursday.

RSS
124678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR